110 related articles for article (PubMed ID: 32245981)
1. A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders.
Holm Nielsen S; Mortensen JH; Willumsen N; Rasmussen DGK; Mogensen DJ; Di Sabatino A; Mazza G; Jørgensen LN; Giuffrida P; Pinzani M; Klinge L; Kjeldsen J; Leeming DJ; Karsdal MA; Genovese F
Sci Rep; 2020 Apr; 10(1):5910. PubMed ID: 32245981
[TBL] [Abstract][Full Text] [Related]
2. Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders.
Jensen C; Nielsen SH; Mortensen JH; Kjeldsen J; Klinge LG; Krag A; Harling H; Jørgensen LN; Karsdal MA; Willumsen N
Cancer Med; 2018 Sep; 7(9):4619-4626. PubMed ID: 30030909
[TBL] [Abstract][Full Text] [Related]
3. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
6. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD.
Lindholm M; Godskesen LE; Manon-Jensen T; Kjeldsen J; Krag A; Karsdal MA; Mortensen JH
Sci Rep; 2021 Jul; 11(1):14713. PubMed ID: 34282237
[TBL] [Abstract][Full Text] [Related]
7. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
8. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
Weigert J; Obermeier F; Neumeier M; Wanninger J; Filarsky M; Bauer S; Aslanidis C; Rogler G; Ott C; Schäffler A; Schölmerich J; Buechler C
Inflamm Bowel Dis; 2010 Apr; 16(4):630-7. PubMed ID: 19714754
[TBL] [Abstract][Full Text] [Related]
10. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
11. Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci.
Drobin K; Assadi G; Hong MG; Andersson E; Fredolini C; Forsström B; Reznichenko A; Akhter T; Ek WE; Bonfiglio F; Hansen MB; Sandberg K; Greco D; Repsilber D; Schwenk JM; D'Amato M; Halfvarson J
Inflamm Bowel Dis; 2019 Jan; 25(2):306-316. PubMed ID: 30358838
[TBL] [Abstract][Full Text] [Related]
12. Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease.
Hatsugai M; Kurokawa MS; Kouro T; Nagai K; Arito M; Masuko K; Suematsu N; Okamoto K; Itoh F; Kato T
J Gastroenterol; 2010 May; 45(5):488-500. PubMed ID: 20049485
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
[TBL] [Abstract][Full Text] [Related]
14. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
16. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
[TBL] [Abstract][Full Text] [Related]
17. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]